Klox Technologies has agreed to sell its professional in-office whitening kit business and teeth-whitening pen business to Valeant Pharmaceuticals International.
Financial terms include an upfront payment and a double-digit royalty stream based on product sales during the next 10 years.
Valeant is planning to launch the products in the U.S. in early 2013 through its dental affiliate, OraPharma.
